Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2021-12-22 00:00:00 ET · period of report 2021-12-20 · accession 0001601485-21-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-22 | 2021-12-20 | ELTX | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.54 | +3,527 | 1.36M | +0.3% | +$8,959 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | P | A | 3,527 | $2.54 | 1,362,013 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.52 to $2.55 inclusive. |